Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
- Tasavon Gholamhoseini M. , et al.
2. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
- Sharafi H. , et al.
3. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection
- Rahimi P. , et al.
4. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
- Sharafi H. , et al.
5. Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
- Rezaee N. , et al.
6. An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
- Alavi M. , et al.
7. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
- Sharafi H. , et al.
8. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting
- Sharafi H. , et al.
9. Incidence, mortality, and burden of hepatitis B and C and geographical distribution in Iran during 2008-2015
- Moradi G. , et al.
10. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank
- Sharafi H. , et al.
11. Association of HCV genotype with viral load among Iranian blood donors: A penalized logistic regression
- Kermani F.R. , et al.
12. Treatment of HCV infection with direct-acting antiviral agents in patients with HIV/HCV co-infection: A systematic review
- Alavian S.M. , et al.
13. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
- Sharafi H. , et al.